1
Views
10
CrossRef citations to date
0
Altmetric
Cell Growth and Development

The Transforming Potential of the c-erbB-2 Protein Is Regulated by Its Autophosphorylation at the Carboxyl-Terminal Domain

, , , , &
Pages 833-842 | Received 19 Jun 1990, Accepted 31 Oct 1990, Published online: 31 Mar 2023

REFERENCES

  • Akiyama, T., T. Kadowaki, E. Nishida, T. Kadooka, H. Ogawara, Y. Fukami, H. Sakai, F. Takaku, and M. Kasuga. 1986. Substrate specificities of tyrosine-specific protein kinases toward cytoskeletal proteins in vitro. J. Biol. Chem. 261:14797-14803.
  • Akiyama, T., T. Saito, H. Ogawara, K. Toyoshima, and T. Yamamoto. 1988. Tumor promoter and epidermal growth factor stimulate phosphorylation of the c-erbB-2 gene product in MKN-7 human adenocarcinoma cells. Mol. Cell. Biol. 8:1019-1026.
  • Akiyama, T., C. Sudo, H. Ogawara, K. Toyoshima, and T. Yamamoto. 1986. The product of the human c-erbB-2 gene: a 185-kilodalton glycoprotein with tyrosine kinase activity. Science 232:1644-1646.
  • Bargmann, C. I., M.-C. Hung, and R. A. Weinberg. 1986. The neu oncogene encodes an epidermal growth factor receptor-related protein. Nature (London) 319:226-230.
  • Bargman, C. I., M.-C. Hung, and R. A. Weinberg. 1986. Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of pl85. Cell 45:649-657.
  • Bargman, C. I., and R. A. Weinberg. 1988. Oncogenic activation of the neu-encoded receptor protein by point mutation and deletion. EMBO J. 7:2043-2052.
  • Berths, P. J., W. S. Chen, L. Hubler, C. S. Lazar, M. G. Rosenfeld, and G. N. Gill. 1988. Alteration of epidermal growth factor receptor activity by mutation of its primary carboxyl-terminal site of tyrosine self-phosphorylation. J. Biol. Chem. 263:3610-3617.
  • Bertics, P. J., and G. N. Gill. 1985. Self-phosphorylation enhances the protein-tyrosine kinase activity of the epidermal growth factor receptor. J. Biol. Chem. 260:14642-14647.
  • Biswas, R., M. Basil, A. Sen-Majumdar, and M. Das. 1985. Intrapeptide autophosphorylation of the epidermal growth factor receptor: regulation of kinase catalytic function by receptor dimerization. Biochemistry 24:3795-3802.
  • Boni-Schnetzler, M., J. B. Rubin, and P. F. Pilch. 1986. Structural requirements for the transmembrane activation of the insulin receptor kinase. J. Biol. Chem. 261:15281-15287.
  • Chen, W. S., C. S. Lazar, M. Poenie, R. R. Tsien, G. N. Gill, and M. G. Rosenfeld. 1987. Requirement for intrinsic protein tyrosine kinase activity in the immediate and late actions of the EGF receptor. Nature (London) 328:820-823.
  • Chou, C. K., T. J. Dull, D. S. Russell, R. Gherzi, D. Lebwohl, A. Ullrich, and O. M. Rosen. 1987. Human insulin receptors mutated at the ATP-binding site lack protein tyrosine kinase activity and fail to mediate postreceptor effects of insulin. J. Biol. Chem. 262:1842-1847.
  • Coussens, L., T. L. Yang-Feng, Y.-C. Liao, E. Chen, A. Gray, J. McGrath, P. H. Seeburg, T. A. Libermann, J. Schlessinger, U. Francke, A. Levinson, and A. Ullrich. 1985. Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene. Science 230:1132-1139.
  • Di Fiore, P. P., J. H. Pierce, M. H. Kraus, O. Segatto, C. R. King, and S. A. Aaronson. 1987. erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells. Science 237:178-182.
  • Downward, J., M. D. Waterfield, and P. J. Paker. 1985. Autophosphorylation and protein kinase C phosphorylation of the epidermal growth factor receptor. J. Biol. Chem. 260:14538-14546.
  • Downward, J., P. Parker, and M. D. Waterfield. 1984. Autophosphorylation sites on the epidermal growth factor receptor. Nature (London) 311:483-485.
  • Ellis, C., M. Moran, F. McCormic, and T. Pawson. 1990. Phosphorylation of GAP and GAP-associated proteins by transforming and mitogenic tyrosine kinases. Nature (London) 343:377-379.
  • Haley, J. D., J. J. Hsuan, and M. D. Waterfield. 1989. Analysis of mammalian fibroblast transformation by normal and mutated human EGF receptors. Oncogene 4:273-283.
  • Hazan, R., B. Margolis, M. Dombalagian, A. Ullrich, A. Zilberstein, and J. Schlessinger. 1990. Identification of autophosphorylation sites of HER2/neu. Cell Growth Differentiation 1:3-7.
  • Heldin, C.-H., C. Betsholtz, L. Claesson-Welsh, and B. Westermark. 1987. Subversion of growth regulatory pathways in malignant transformation. Biochem. Biophys. Acta 907:219-244.
  • Honegger, A., T. J. Dull, F. Bellot, E. Van Obberghen, D. Szapary, A. Schmidt, A. Ullrich, and J. Schlessinger. 1988. Biological activities of EGF receptor mutants with individually altered autophosphorylation sites. EMBO J. 7:3045-3052.
  • Hunter, T., and J. A. Cooper. 1985. Protein-tyrosine kinases. Annu. Rev. Biochem. 54:897-930.
  • Kadowaki, T., M. Kasuga, K. Tobe, F. Takaku, E. Nishida, H. Sakai, S. Koyasu, I. Yahara, K. Toyoshima, T. Yamamoto, and T. Akiyama. 1987. An Mr= 190,000 glycoprotein phosphorylated on tyrosine residues in epidermal growth factor-stimulated KB cells is the product of the c-erbB-2 gene. Biochem. Biophys. Res. Commun. 144:699-704.
  • Kamps, M. P., and B. M. Sefton. 1988. Identification of multiple novel polypeptide substrates of the v-src, v-yes, v-fps, v-ros, and v-erbB oncogenic tyrosine protein kinases utilizing antisera against phosphotyrosine. Oncogene 2:305-315.
  • King, C. R., M. H. Kraus, and S. A. Aaronson. 1985. Amplification of a novel v-erbB-related gene in human mammary carcinoma. Science 229:974-976.
  • Kokai, Y., J. A. Cohen, J. A. Drebin, and M. I. Greene. 1987. Stage- and tissue-specific expression of the neu oncogene in rat development. Proc. Natl. Acad. Sci. USA 84:8498-8501.
  • Koland, J. G., and R. A. Cerione. 1988. Growth factor control of epidermal growth factor receptor kinase activity via an intramolecular mechanism. J. Biol. Chem. 263:2230-2237.
  • Linder, M. E., and J. G. Burr. 1988. Nonmyristoylated p60v-src fails to phosphorylate proteins of 115-120 kDa in chicken embryo fibroblasts. Proc. Natl. Acad. Sci. USA 85:2608-2612.
  • Lupu, R., R. Colomer, G. Zugmeier, J. Samp, M. Shepard, D. Slamon, and M. E. Lippman. 1990. Direct interaction of a ligand for the erbB-2 oncogene product with the EGF receptor and ppl85erbB-2. Science 249:1552-1555.
  • Margolis, B., S. G. Rhee, S. Felder, M. Mervic, R. Lyall, A. Levitzki, A. Ullrich, A. Zilberstein, and J. Schlessinger. 1989. EGF induces tyrosine phosphorylation of phospholipase C-II: a potential mechanism for EGF receptor signaling. Cell 57:1101-1107.
  • Meisenhelder, J., P.-G. Sun, S. G. Rhee, and T. Hunter. 1989. Phospholipase C-γ is a substrate for the PDGF and EGF receptor protein-tyrosine kinases in vivo and in vitro. Cell 57:1109-1122.
  • Mori, S., T. Akiyama, Y. Yamada, Y. Morishita, I. Sugawara, K. Toyoshima, and T. Yamamoto. 1989. C-erbB-2 gene product, a membrane protein commonly expressed on fetal epithelial cells. Lab. Invest. 61:93-97.
  • Morrison, D. K., D. K. Kaplan, U. Rapp, and T. M. Roberts. 1988. Signal transduction from membrane to cytoplasm: growth factors and membrane-bound oncogene products increase Raf-1 phosphorylation and associated protein kinase activity. Proc. Natl. Acad. Sci. USA 85:8855-8859.
  • Pang, D. T., B. R. Sharma, and J. A. Shafer. 1985. Purification of the catalytically active phosphorylated form of insulin receptor kinase by affinity chromatography with O-phosphotyrosyl-binding antibodies. Arch. Biochem. Biophys. 242:176-186.
  • Pike, L. J., B. Gallis, J. E. Casnellie, P. Bornstein, and E. G. Krebs. 1982. Epidermal growth factor stimulates the phosphorylation of synthetic tyrosine-containing peptides by A431 cell membranes. Proc. Natl. Acad. Sci. USA 79:1443-1447.
  • Segatto, O., F. Lonardo, J. H. Pierce, D. P. Bottaro, and P. P. Di Fiore. 1990. The role of autophosphorylation in modulation of erbB-2 transforming function. New Biol. 2:187-195.
  • Semba, K., N. Kamata, K. Toyoshima, and T. Yamamoto. 1985. A v-erbB-related protooncogene, c-erbB-2, is distinct from the c-erbB-1/epidermal growth factor receptor gene and is amplified in a human salivary gland adenocarcinoma. Proc. Natl. Acad. Sci. USA 82:6497-6501.
  • Slamon, D. J., G. M. Clark, S. G. Wong, W. J. Levin, A. Ullrich, and W. L. McGuire. 1987. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235:177-182.
  • Stern, D. F., P. A. Heffernan, and R. A. Weinberg. 1986. pl85, a protein associated with tyrosine kinase activity. Mol. Cell. Biol. 6:1729-1740.
  • Stern, D. F., M. P. Kamps, and H. Cao. 1988. Oncogenic activation of p185neu stimulates tyrosine phosphorylation in vivo. Mol. Cell. Biol. 8:3969-3973.
  • Taylor, J. W., J. Ott, and F. Eckstein. 1985. The rapid generation of oligonucleotide-directed mutations at high frequency using phosphorothiate-modified DNA. Nucleic Acids Res. 13:8765-8785.
  • Wahl, M. I., S. Nishibe, P.-G. Sun, S. G. Rhee, and G. Carpenter. 1989. Epidermal growth factor stimulates tyrosine phosphorylation of phospholipase C-II independent of receptor internalization and extracellular calcium. Proc. Natl. Acad. Sci. USA 86:1568-1572.
  • Weiner, D. B., J. Liu, J. A. Cohen, W. V. Williams, and M. I. Green. 1989. A point mutation in the neu oncogene mimics ligand induction of receptor aggregation. Nature (London) 339:230-231.
  • Yamamoto, T., S. Ikawa, T. Akiyama, K. Semba, N. Nomura, N. Miyajima, T. Saito, and K. Toyoshima. 1986. Similarity of protein encoded by the human c-erbB-2 gene to epidermal growth factor receptor. Nature (London) 319:230-234.
  • Yarden, Y., and J. Schlessinger. 1987. Self-phosphorylation of epidermal growth factor receptor: evidence for a model of intermolecular allosteric activation. Biochemistry 26:1434-1442.
  • Yokota, J., T. Yamamoto, N. Miyajima, K. Toyoshima, N. Nomura, H. Sakamoto, M. Terada, and T. Sugimura. 1988. Genetic alterations of the c-erbB-2 oncogene occur frequently in tubular adenocarcinoma of the stomach and are often accompanied by amplification of the v-erbA homologue. Oncogene 2:283-287.
  • Yokota, J., T. Yamamoto, K. Toyoshima, M. Terada, T. Sugimura, H. Battifora, and M. J. Cline. 1986. Amplification of c-erbB-2 oncogene in human adenocarcinomas in vivo. Lancet i:765-767.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.